Micromedic is a publicly traded company listed on the Tel Aviv Stock Exchange. The Company's main business is licensing, translating and commercializing new promising early-detection and monitoring biomarkers for various autoimmune clinical conditions.
Micromedic has created collaborations and strategic alliances with leading research and clinical institutes in Israel and in the US. Micromedic is currently collaborating with Hadassah Medical Center in Jerusalem, Tel Aviv Medical Center, University of Florida and The Technion - Israel Institute of Technology.
Mission Statement
To bridge the gap between preliminary clinical study and clinical needs, in order to create sensitive reliable new Biomarkers/Diagnostic tests, approved by the FDA and ready for commercialization.
___________________________________________________________________________________________________________
News...
The Company
Micromedic Technologies Ltd
Industry
Biotech-Molecular Diagnostics
Type
Public [Tel Aviv Stock Exchange]
Symbol
MCTC
Pipeline
Life Saving Biomarkers for major type of Cancer & Diabetes
Micromedic
Life Saving - Molecular Diagnostics
For Cancer & Diabetes
